(E)-N-(2-(tert-Butylamino)-1-(3,4-dimethoxyphenyl)-2-oxoethyl)-N-cyclopropyl-4-oxo-4-(p-tolyl)but-2-enamide

ID: ALA4515694

Chembl Id: CHEMBL4515694

PubChem CID: 155539709

Max Phase: Preclinical

Molecular Formula: C28H34N2O5

Molecular Weight: 478.59

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(C(C(=O)NC(C)(C)C)N(C(=O)/C=C/C(=O)c2ccc(C)cc2)C2CC2)cc1OC

Standard InChI:  InChI=1S/C28H34N2O5/c1-18-7-9-19(10-8-18)22(31)14-16-25(32)30(21-12-13-21)26(27(33)29-28(2,3)4)20-11-15-23(34-5)24(17-20)35-6/h7-11,14-17,21,26H,12-13H2,1-6H3,(H,29,33)/b16-14+

Standard InChI Key:  GTENTLZUYBDEIB-JQIJEIRASA-N

Alternative Forms

  1. Parent:

    ALA4515694

    ---

Associated Targets(Human)

TXNRD1 Tclin Thioredoxin reductase 1 (99 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Txnrd1 Thioredoxin reductase 1, cytoplasmic (45279 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 478.59Molecular Weight (Monoisotopic): 478.2468AlogP: 4.40#Rotatable Bonds: 9
Polar Surface Area: 84.94Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.90CX LogD: 3.90
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.43Np Likeness Score: -0.89

References

1. Jovanović M, Zhukovsky D, Podolski-Renić A, Domračeva I, Žalubovskis R, Senćanski M, Glišić S, Sharoyko V, Tennikova T, Dar'in D, Pešić M, Krasavin M..  (2019)  Novel electrophilic amides amenable by the Ugi reaction perturb thioredoxin system via thioredoxin reductase 1 (TrxR1) inhibition: Identification of DVD-445 as a new lead compound for anticancer therapy.,  181  [PMID:31400708] [10.1016/j.ejmech.2019.111580]

Source